Ohio-Bound

High-tech startups are popping up in unexpected cities, reports the Wall Street Journal. Instead of flocking to Boston or the Bay Area, companies are opening up or remaining in Ohio and Michigan. The founder of Proxy Biomedical Peter Gingras, based in Galway, Ireland, turned to Cleveland to open his US-based operations. "The State of Ohio, the City of Cleveland and the Cleveland Clinic stepped up and put a competitive package together. In the end, it was an easy decision," Gingras says.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.